Delayed-release Multi Matrix System (MMX) mesalazine in ulcerative colitis: a viewpoint by Cosimo Prantera

Drugs. 2007;67(17):2643-4. doi: 10.2165/00003495-200767170-00012.
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Colitis, Ulcerative / drug therapy*
  • Delayed-Action Preparations
  • Drug-Related Side Effects and Adverse Reactions
  • Humans
  • Mesalamine / administration & dosage
  • Mesalamine / therapeutic use*
  • Sensitivity and Specificity

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Delayed-Action Preparations
  • Mesalamine